You are here

Pfizer

Steere’s Exit Could Mean Pfizer Is Serious About Changing

Forbes

Thu, 03/24/11 - 01:44 pm

Boehringer, Pfizer’s Spiriva Bests Glaxo Drug for Lung Disorder

Bloomberg

Thu, 03/24/11 - 09:33 am

Boehringer Ingelheim

What Biotech Wants From Big Pharma Partners: Survey Says!?

InVivo

Wed, 03/23/11 - 10:29 am

Pharmas in the Doghouse

Motley Fool

Tue, 03/22/11 - 10:06 pm

Pfizer Lipitor Subsidy May Affect Ranbaxy, Deutsche Says

Bloomberg

Tue, 03/22/11 - 09:23 am

Comparing Medivation, Inc.'s and Johnson & Johnson's Prostate Cancer Drugs

Seeking Alpha

Mon, 03/21/11 - 02:56 pm

prostate cancer

DSM Likely Interested in Pfizer Nutrition Unit, Cheuvreux Says

Bloomberg

Mon, 03/21/11 - 11:35 am

Don't Miss This Buffett-Type Business

Motley Fool

Sat, 03/19/11 - 10:42 am

Mead Johnson Nutrition

Pfizer brings new chewable Viagra to Mexico

Reuters

Fri, 03/18/11 - 11:06 am

erectile dysfunction

EMA Recommends Approval for Pfizer, Bristol-Myers’ Eliquis

Bloomberg

Fri, 03/18/11 - 10:22 am

Interview: Pfizer vaccine unit eyes adults, infectious disease

Fierce Biotech

Thu, 03/17/11 - 11:11 am

Pfizer Baby Food Unit Gets $6.8 Billion in Mead Model: Real M&A

Bloomberg

Thu, 03/17/11 - 10:47 am

Auxilium Pharma in Neutral Lane

Yahoo/Zacks.com

Wed, 03/16/11 - 09:55 pm

How Pfizer’s Breakup Plan May Explain Sudden Exit of Former CEO

BNET Pharma

Wed, 03/16/11 - 04:40 pm

A Big Pain for Pfizer: Embeda Is Recalled

Seeking Alpha

Wed, 03/16/11 - 10:43 am

Extending the Competition in Parkinson's Disease

Motley Fool

Wed, 03/16/11 - 09:17 am

Parkinson's Disease

Pfizer: Bigger Not Necessarily Better

Seeking Alpha

Wed, 03/16/11 - 09:16 am

Making sense of the Alzheimer's drug pipeline

Fierce Biotech Research

Tue, 03/15/11 - 12:31 pm

Alzheimer's disease

Ortho-McNeil-Janssen

Novartis Has Largest Japan Exposure Among Big Pharma

Barron's

Tue, 03/15/11 - 11:08 am

Bristol-Myers Squibb

Pages